Atlassian Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Atlassian Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2021	FY2023	FY2024	FY2025	FY2026
Revenue	627	881	1,210	1,614	2,089	2,803	3,535	4,359	5,215	6,572
Cost of revenue	119	173	210	269	332	453	634	803	895	997
Gross profit	508	708	1,000	1,345	1,757	2,350	2,901	3,555	4,320	5,575
Research and development	310	416	579	763	933	1,292	1,870	2,184	2,669	3,269
Selling and marketing					372	536	770	877	1,135	1,541
General and administrative					311	452	606	611	647	755
Operating expenses					1,616	2,280	3,246	3,672	4,451	5,565
Operating income	-55.8	-46	-63.4	14.1	141	70.1	-345	-117	-130	10.4
Interest expense	0.08	6.81	40.2	49.6	92.6	41.5	30.1	34.1	30.6	49.5
Interest income	4.85	9.88	33.5	27.8	7.16	2.28	49.7	96.7	112	69.7
Other non-operating income					-570	-502	14.5	-30.9	-50.3	-8.57
Pre-tax income	-52.4	-58.1	-606	-346	-514	-471	-311	-85.4	-98.9	22.1
Income tax	-15	55.3	32.1	4.45	64.6	48.6	176	215	158	75.9
Net income	-37.4	-113	-638	-351	-579	-520	-487	-301	-257	-53.8
EBITDA	5.71	33.4	6.89	76.4	197	122	-284	-38.3	-38	151
EPS, basic	-0.14	-0.41	-2.22	-1.19	-2.32	-2.05	-1.90	-1.16	-0.98	-0.21
EPS, diluted	-0.14	-0.41	-2.22	-1.19	-2.32	-2.05	-1.90	-1.16	-0.98	-0.21
Shares, basic (weighted)					250	253	256	259	262	260
Shares, diluted (weighted)					250	253	256	259	262	260

Balance sheet

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2021	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	244	1,410	1,268	1,489	919	1,385	2,103	2,177	2,513	1,240
Short-term investments	305	323	445	676	313	73.3	10	162	424	0
Receivables	26.8	46.1				308	478	628	778	1,270
Other current assets						70	146	109	176	288
Total current assets	612	1,822	2,042	2,644	1,628	1,897	2,736	3,076	3,891	2,797
Property, plant and equipment	41.2	51.7	81.5	97.6	66.2	101	81.4	86.3	105	86.3
Lease right-of-use assets			241	218	205	277	184	172	169	114
Goodwill	312	312	609	645	716	723	727	1,289	1,304	2,303
Intangible assets	121	63.6	151	130	125	101	69.1	299	245	432
Other non-current assets						58.9	73.1	62.1	101	154
Total assets	1,284	2,422	2,977	3,894	2,945	3,327	4,107	5,212	6,042	6,104
Accounts payable	73.2	108	159	203	266	81.2	159	178	222	263
Accrued liabilities						406	423	577	682	765
Deferred revenue						1,066	1,363	1,806	2,227	2,495
Short-term debt						0	37.5	0
Total current liabilities	327	445	2,330	3,019	2,310	1,594	2,028	2,610	3,181	3,571
Long-term debt						999	962	986	988	990
Lease liabilities				230	214	274	238	214	201	195
Other non-current liabilities						14.6	31.2	39.9	48.2	95.4
Total liabilities	390	1,515	2,412	3,319	2,650	2,999	3,452	4,179	4,696	5,045
Total debt						999	1,000	986	988	990
Paid-in capital	451	455	458	460	461	2,183	3,131	4,212	5,574	7,181
Retained earnings	-14.6	-128	-766	-1,116	-1,813	-1,869	-2,510	-3,205	-4,242	-6,105
Other comprehensive income						13.9	34	25.3	13.2	-17
Shareholders' equity	903	907	565	567	313	327	655	1,033	1,346	1,058
Total equity	894	907	565	575	295	336	655	1,033	1,346	1,058
Total liabilities and equity	1,284	2,422	2,977	3,894	2,945	3,327	4,107	5,212	6,042	6,104

Cash flow statement

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2021	FY2023	FY2024	FY2025	FY2026
Net income	-37.4	-113	-638	-351	-579	-520	-487	-301	-257	-53.8
Depreciation and amortization	61.5	79.4	70.2	62.3	56	51.7	60.9	78.7	92.4	141
Stock-based compensation					341	525	948	1,081	1,362	1,607
Deferred income tax					-8.98	-3.32	8.18	0.01	4.6	-23.1
Change in receivables					-61.3	-135	-170	-148	-150	-484
Change in payables					10.4	31.7	78.9	18.2	42.9	41.9
Cash from operations	199	311	466	574	790	821	868	1,448	1,460	1,353
Capital expenditures	-0.93	-30.2	-44.2	-35.7	-31.5	-70.6	-25.8	-33.1	-44.9	-34.1
Acquisitions					-91.8	-19.4	-5.78	-848	-14.2	-1,229
Purchases of investments					-109	-21	-24.8	-249	-412	-67.3
Sales and maturities of investments					455	76.9	74	117	145	144
Cash from investing	-225	-51.7	-604	-319	259	36.5	-1.26	-964	-342	-807
Debt issued				0	0	1,000
Debt repaid		0	0	-0	-1,803	-1,549	0	-1,000	0	0
Share buybacks					0	0	-150	-395	-779	-1,800
Cash from financing	9.44	907	-3.19	-42.6	-1,603	-399	-148	-408	-783	-1,800
Exchange rate effect	0.47	-0.63	-0.86	-1.18	5.41	-9.19
Net change in cash	-15.3	1,166	-142	212	-549	449	717	74.2	336	-1,264
Free cash flow	198	281	422	539	758	750	842	1,415	1,416	1,319
Interest paid					6.5	10	46.2	61.3	54.3	54.3
Income taxes paid	9.04	4.25	-7.04	17.9	50.3	66.6	102	254	180	161

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $187.74 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	84.8%	Gross profit / revenue.
Operating margin	0.2%	Operating income / revenue.
EBITDA margin	2.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	0.3%	Pre-tax income / revenue.
Net margin	-0.8%	Net income / revenue.
FCF margin	20.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	20.6%	Cash from operations / revenue.
Effective tax rate	344.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	-4.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-0.9%	Net income / average total assets.
Return on invested capital (ROIC)	2.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	49.7%	Research and development expense / revenue.
Stock-based pay / revenue	24.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.5%	Capital expenditures / revenue.
D&A / revenue	2.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	26.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	23.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	25.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	29.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	24.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	26.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 5y	-40.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-5.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-7.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	15.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	11.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-6.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	16.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	11.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-21.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	17.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	27.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	14.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	15.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.78x	Current assets / current liabilities.
Quick ratio	0.70x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.35x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.93x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	16.2%	Total debt / total assets.
Liabilities / assets	82.7%	Total liabilities / total assets.
Net debt	-$250.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-1.66x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.21x	Operating income / interest expense.
Working capital	-$774.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	44.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.68B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.08x	Revenue / average total assets.
Fixed asset turnover	68.7x	Revenue / average property, plant and equipment.
Receivables turnover	6.42x	Revenue / average receivables.
Days sales outstanding	57 days	365 x average receivables / revenue.
Days payables	89 days	365 x average accounts payable / cost of revenue.
Capex / operating cash flow	2.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.21	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$0.21	Net income per basic share, as reported (split-adjusted).
Revenue per share	$25.26	Revenue / diluted weighted shares.
FCF per share	$5.07	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.20	Cash from operations / diluted weighted shares.
Book value per share	$4.07	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$6.44	Tangible book value / shares outstanding.
Cash per share	$4.76	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	136.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$47.52B	Share price x shares outstanding.
Enterprise value	$47.27B	Market cap + total debt - cash - short-term investments.
P/S	7.23x	Market cap / revenue.
P/B	44.9x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	36.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	35.1x	Market cap / cash from operations, when positive.
EV/Sales	7.19x	Enterprise value / revenue.
EV/EBIT	4,565x	Enterprise value / operating income, when both are positive.
EV/EBITDA	313x	Enterprise value / EBITDA, when both are positive.
EV/FCF	35.8x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.8%	Free cash flow / market cap.
Earnings yield	-0.1%	Net income / market cap (the inverse of P/E).
Shareholder yield	3.8%	(Dividends paid + share buybacks) / market cap.

What was Atlassian Corp's revenue in fiscal 2026?

Atlassian Corp reported revenue of $6.57B for fiscal 2026, 26% higher than the year before.

Was Atlassian Corp profitable in fiscal 2026?

No. It reported a net loss of $53.8M.

How much free cash flow did Atlassian Corp generate in fiscal 2026?

Cash from operations of $1.35B minus capital expenditures of $34.1M left free cash flow of $1.32B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Atlassian Corp